Comparison of the effects of propofol and sevoflurane induced burst suppression on cerebral blood flow and oxygenation: a prospective, randomised, double blinded study.
Pharmacologically induced EEG silence increases tolerance of ischemic period by reducing cerebral metabolism. We hypothesised that sevoflurane, a cerebral vasodilator, will maintain cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) better than propofol, a cerebral vasoconstrictor, during EEG silence. To validate this, we compared the effect of sevoflurane and propofol on CBF and CMRO2 during surgical plane of anaesthesia (SP) and burst suppression on EEG (BS). We conducted a prospective, double blinded trial, where patients undergoing neurosurgery were randomised to receive propofol or sevoflurane. Mean velocity (MV) and pulsatility index (PI) of bilateral middle cerebral arteries (MCA) were measured as surrogate of CBF. Jugular venous oxygen saturation (SjvO2) and arterio-venous oxygen difference (AjvDO2) were obtained to assess CMRO2. The values were compared between groups using student t test and within the group with ANOVA at SP and BS. - BS decreased MV and increased PI in propofol group (p<0.001 and p<0.02 on normal side, p<0.004 and p<0.001 on tumor side). There was no significant change in sevoflurane group. BS with sevoflurane increased SjvO2 (p<0.001) and decreased AjvDO2 (p<0.001). Change in SjvO2 and AjvDO2 with propofol at SP and BS was variable. In our study, sevoflurane had a safer profile on cerebral oxygenation during BS while not altering the CBF, suggesting increased availability of oxygen. Propofol, on the other hand, produced cerebral vasoconstriction with BS. The effect of propofol on oxygenation was unpredictable, with low SjvO2 and high AjvDO2 even at surgical plane of anesthesia.